| Area | Company | 公司 |
|---|---|---|
| Cardiovascular | IMMEDIATE Therapeutics | IMMEDIATE Therapeutics |
| Cardiovascular | Rednvia | Rednvia |
| Cell Therapy, RA | Kolon Life Science | Kolon Life Science |
| CNS | Astrocyte Pharmaceuticals | Astrocyte Pharmaceuticals |
| CNS | Jingxin Pharmaceutical Co.,LTD. | 京新药业 |
| CNS | WEX Pharmaceuticals Inc. | WEX Pharmaceuticals Inc. |
| CNS | WinSanTor Inc | WinSanTor Inc |
| CNS | Yiling Pharma | 以岭药业 |
| CNS, Cardiovascular, eye | BSIM Therapeutics | BSIM Therapeutics |
| CNS, oncology | GENUV | GENUV |
| CNS; Oncology | Elixiron Immunotherapeutics | 安立玺荣生物 |
| CNS;Fundraising | Ophidion, Inc. | Ophidion, Inc. |
| Dentin Hypersensitivity | HysensBio | HysensBio |
| Drug delivery | Coastar Therapeutics | Coastar Therapeutics |
| Drug delivery platform; Fundraising | Turn Therapeutics | Turn Therapeutics |
| Eye Disease | VivaVision Biotech Inc. | 维眸生物 |
| Gene Therapy; Eye Disease | Neurophth | 纽福斯生物 |
| GI | Afimmune | Afimmune |
| GI | Carephar | 科菲平 |
| GI | Inorbit Therapeutics ab | Inorbit Therapeutics ab |
| GI | BYOMass, Inc. | BYOMass, Inc. |
| GI | ENYO Pharma | ENYO Pharma |
| Infectious Disease | Aptorum Group Limited | Aptorum Group Limited |
| Infectious Disease | Hexima Limited | Hexima Limited |
| Infectious Disease | VESALE BIOSCIENCE SRL | VESALE BIOSCIENCE SRL |
| Infectious Disease; Fundraising | ANTABIO | ANTABIO |
| Medical Device | BD (China) | BD (China) |
| Medical Device | Continale | Continale |
| Medical Device | Escala Medical | Escala Medical |
| Medical Device | M3dicine | M3dicine |
| Medical Device | Omeq Medical | Omeq Medical |
| Medical Device | Recovery Plus | 术康 |
| Medical Device | Spear Bio | Spear Bio |
| Medical Device | Trendline | Trendline |
| Medical Device | ElastiMed | ElastiMed |
| Medical Device | InfanDx | InfanDx |
| Medical Device | densys3D | densys3D |
| Metabolic disease | Huadong Medicines | 华东医药 |
| Metabolic disease | Immunwork, Inc | Immunwork, Inc |
| Oncology | AI Therapeutics | AI Therapeutics |
| Oncology | Alphamab Oncology | 康宁杰瑞生物制药 |
| Oncology | AUM Biosciences | AUM Biosciences |
| Oncology | AVM Biotech | AVM Biotech |
| Oncology | Biocytogen | 百奥赛图医药 |
| Oncology | CARsgen Therapeutics | 科济生物 |
| Oncology | Fosun Orinove | 复星弘创 |
| Oncology | Gluetacs Therapeutics | 标新生物 |
| Oncology | Hinova Pharmaceuticals Inc | 成都海创 |
| Oncology | ImmuneOnco Biopharma | 宜明昂科 |
| Oncology | Immunophage | 艾美斐 |
| Oncology | Kintor Pharma | 开拓药业 |
| Oncology | Mabwell Bioscience | 迈威生物 |
| Oncology | MedAbome, Inc. | MedAbome, Inc. |
| Oncology | Neukio Biotherapeutics | 星奕昂生物 |
| Oncology | Nordic Nanovector | Nordic Nanovector |
| Oncology | Oncolys BioPharma Inc. | Oncolys BioPharma Inc. |
| Oncology | OnCusp Pharma | 昂阔药业 |
| Oncology | OneThree Biotech | OneThree Biotech |
| Oncology | PharmAbcine | PharmAbcine |
| Oncology | Sinotau Pharmaceutical | 先通医药 |
| Oncology | TransThera Sciences | 药捷安康科技 |
| Oncology | Virogin | 复诺健生物 |
| Oncology | Vivan Therapeutics | Vivan Therapeutics |
| Oncology | Wayshine Biopharm, Inc | 威尚生物 |
| Oncology | Wuhan Binhui Biopharma | 滨会生物 |
| Oncology | YZY Bio | 友芝友 |
| Oncology | Lanthio Pharma | Lanthio Pharma |
| Oncology | Lytix Therapeutics | Lytix Therapeutics |
| Oncology, GI, immune, CNS | Anji Biotechnology | 安吉生物 |
| Oncology; platform | Lena Biosciences, Inc. | Lena Biosciences, Inc. |
| Oncology, Eye Disease | Kanaph | Kanaph |
| Oncology; Fundraising | Denovo | Denovo |
| Oncology; License-in | Purple Biotech | Purple Biotech |
| Oncology; platform; Fundrising | NuvOx Pharma, LLC | NuvOx Pharma, LLC |
| Oncology; platform; CNS, Eye Diseases, Cardiovascular | Microvascular Therapeutics | Microvascular Therapeutics |
| RA | Oryn Therapeutics | Oryn Therapeutics |
| Respiratory | Yuanxi Medicine | 元熙医药 |
| Respiratory | HuiTai Biomedicine | 惠泰生物 |
| Respiratory system; CNS; Oncology | Haisco Pharma | 海思科药业 |
| Skin Disease | Qyuns Therapeutics | 荃信生物医药 |
| Women Health | VaRi Bioscience GmbH | VaRi Bioscience GmbH |
Tentative presenting list as of Dec 22, updated one will be shown at Agenda.